Infusion fluids contain harmful glucose degradation products, Intensive Care Med, vol.36, pp.1213-1220, 2010. ,
Handbook on Injectable Drugs, 2011. ,
,
4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis, Kidney Int, vol.3, pp.697-703, 2002. ,
Monograph 5.1.1. Methods of preparation of sterile products, p.9, 2017. ,
HPLC studies on the degradation profiles of glucose 5% solutions subjected to heat sterilization in a microprocessor-controlled autoclave, J. Clin. Pharm. Ther, vol.14, pp.189-195, 1989. ,
3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis, Perit. Dial. Int, vol.18, pp.290-293, 1998. ,
Temperature: the single most important factor for degradation of glucose fluids during storage, Perit. Dial. Int, vol.24, pp.385-391, 2004. ,
Development and validation of an HPLC method to quantify 3,4-dideoxyglucosone-3-ene in peritoneal dialysis fluids, Biomed. Chromatogr, vol.23, pp.843-851, 2009. ,
Impact of 3,4-dideoxyglucosone-3-ene (3,4-DGE) on cytotoxicity of acidic heat-sterilized peritoneal dialysis fluid, J. Artif. Organs, vol.10, pp.47-51, 2007. ,
Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose, Biochem. J, vol.344, pp.109-116, 1999. ,
Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects: a study of residual fluid and mesothelial cells, Perit. Dial. Int, vol.21, pp.607-610, 2001. ,
Baking, ageing, diabetes: a short history of the Maillard reaction, Angew. Chem. Int. Ed Engl, vol.53, pp.10316-10329, 2014. ,
Determination of advanced glycation endproducts in cooked meat products, Food Chem, vol.168, pp.190-195, 2015. ,
A chromatographic quality control procedure based on HPLC for 5-hydroxymethylfurfural in autoclaved D-glucose infusion fluids, J. Clin. Hosp. Pharm, vol.7, pp.17-23, 1982. ,
Reversed-phase high-performance liquid chromatographic method for the quantification of 5-hydroxymethylfurfural as the major degradation product of glucose in infusion fluids, J. Chromatogr. A, vol.467, pp.395-401, 1989. ,
A review of 5-hydroxymethylfurfural (HMF) in parenteral solutions, Fundam. Appl. Toxicol, vol.4, pp.843-853, 1984. ,
3,4-DGE is cytotoxic and decreases HSP27/HSPB1 in podocytes, Arch. Toxicol, vol.88, pp.597-608, 2014. ,
3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis, Kidney Int, vol.68, pp.1303-1311, 2005. ,
The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products, Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. -Eur. Ren. Assoc, vol.19, pp.2208-2216, 2004. ,
Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases, Prog. Retin. Eye Res, vol.42, pp.85-102, 2014. ,
Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis, Perit. Dial. Int. J. Int. Soc. Perit. Dial, vol.27, issue.2, pp.205-209, 2007. ,
Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects: a study of residual fluid and mesothelial cells, Perit. Dial. Int. J. Int. Soc. Perit. Dial, vol.21, pp.607-610, 2001. ,
Measurement of protein glycation, glycated peptides, and glycation free adducts, Perit. Dial. Int. J. Int. Soc. Perit. Dial, vol.25, pp.522-533, 2005. ,
The Effect of Low-GDP Solution on Ultrafiltration and Solute Transport in Continuous Ambulatory Peritoneal Dialysis Patients, Perit. Dial. Int, vol.33, pp.382-390, 2013. ,
Effects of low-glucose degradation product solution on peritoneal membrane characteristics in peritoneal dialysis patients: a 3-year follow-up study, Iran. J. Kidney Dis, vol.8, pp.58-64, 2014. ,
GDPs and AGEs: impact on cardiovascular toxicity in dialysis patients, Adv. Perit. Dial, vol.27, pp.22-26, 2011. ,
Glucose degradation products result in cardiovascular toxicity in a rat model of renal failure, Perit. Dial. Int. J. Int. Soc. Perit. Dial, vol.30, pp.35-40, 2010. ,
Baseline serum interleukin-6 predicts cardiovascular events in incident peritoneal dialysis patients, Perit. Dial. Int. J. Int. Soc. Perit. Dial, vol.35, pp.35-42, 2015. ,
Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure, Eur. J. Clin. Invest, vol.38, pp.296-305, 2008. ,
Cardiometabolic syndrome and chronic kidney disease: what is the link?, J. Cardiometab. Syndr, vol.1, pp.58-65, 2006. ,
Role of advanced glycation end product (AGE)-induced receptor (RAGE) expression in diabetic vascular complications, Microvasc. Res, vol.95, pp.1-6, 2014. ,
Various techniques for the routine evaluation of the degradation of glucose in parenteral solutions -a critical study, J. Pharm. Biomed. Anal, vol.5, pp.309-318, 1987. ,
Glycation during storage and administration of monoclonal antibody formulations, Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahrenstechnik EV, vol.70, pp.42-50, 2008. ,
A study in glycation of a therapeutic recombinant humanized monoclonal antibody: where it is, how it got there, and how it affects charge-based behavior, Anal. Biochem, vol.373, pp.179-191, 2008. ,
How to Avoid Glucose Degradation Products in Peritoneal Dialysis Fluids, Perit. Dial. Int, vol.26, pp.490-497, 2006. ,
Development of toxic degradation products during heat sterilization of glucose-containing fluids for peritoneal dialysis: influence of time and temperature, Perit. Dial. Int, vol.15, pp.26-32, 1995. ,
The effect of the gas permeability of plastics on the stability of thiomersal ,
, , vol.36, pp.683-685, 1981.
Compatibility and stability of additives in parenteral nutrition admixtures, Nutr. Burbank Los Angel. Cty. Calif, vol.14, pp.697-706, 1998. ,
Migration of plasticizers from PVC medical devices: Development of an infusion model, Int. J. Pharm, vol.494, pp.136-145, 2015. ,
The impact of preoperative micronutrient supplementation in lung surgery. A prospective randomized trial of oral supplementation of combined alpha-ketoglutaric acid and 5-hydroxymethylfurfural, Eur. J. Cardio-Thorac. Surg. Off. J. Eur. Assoc. Cardio-Thorac. Surg, vol.32, pp.776-782, 2007. ,
In-vitro metabolism and protein binding of 5-HMF, a potential antisickling agent, Theses Diss, 2010. ,
The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products, Nephrol. Dial. Transplant, vol.19, pp.2208-2216, 2004. ,
Levels of 5-hydroxymethylfurfural in dextrose injection, Am. J. Hosp. Pharm, vol.34, pp.205-206, 1977. ,
, Les Plastiques: Polymères, Transformations et Applications. Hermes, p.48, 1991.